Inventor
CORTE JAMES R
US65 patents
⚠️ This page may combine multiple inventors who share the name “CORTE JAMES R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
43 patentsUS10662172B2May 26, 2020
Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO30 citations94
US10576062B2Mar 3, 2020
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO18 citations93
US10071078B2Sep 11, 2018
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO21 citations93
US9453018B2Sep 27, 2016
Pyrimidinones as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO13 citations92
US7626039B2Dec 1, 2009
Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO14 citations92
US7459564B2Dec 2, 2008
Substituted biaryl compounds as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO26 citations92
US7453002B2Nov 18, 2008
Five-membered heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO24 citations92
US7417063B2Aug 26, 2008
Bicyclic heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO27 citations92
US7141578B2Nov 28, 2006
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO17 citations92
US7429604B2Sep 30, 2008
Six-membered heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO35 citations90
US10487086B2Nov 26, 2019
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US10208068B2Feb 19, 2019
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO5 citations84
US9902742B2Feb 27, 2018
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO5 citations84
US9802939B2Oct 31, 2017
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US9611274B2Apr 4, 2017
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO5 citations84
US9108951B2Aug 18, 2015
Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO5 citations84
US7645799B2Jan 12, 2010
Substituted biaryl compounds as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO7 citations74
US11136327B2Oct 5, 2021
Macrocycles as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO1 citations73
US11053247B2Jul 6, 2021
Pyrimidinones as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US11007180B2May 18, 2021
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO3 citations72
US10336754B2Jul 2, 2019
Pyrimidinones as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US9777001B2Oct 3, 2017
Macrocycles with aromatic P2′ groups as factor xia inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US10336730B2Jul 2, 2019
Substituted glycine derived FXIA inhibitors
BRISTOL MYERS SQUIBB CO1 citations63
US12428421B2Sep 30, 2025
Pyrimidinones as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US12404274B2Sep 2, 2025
Macrocycles as factor xia inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US12195444B2Jan 14, 2025
Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations62
US11697646B2Jul 11, 2023
Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations62
US11352345B2Jun 7, 2022
Cyclohexyl acid pyrazole azoles as LPA antagonists
BRISTOL MYERS SQUIBB CO1 citations62
US11319315B2May 3, 2022
Cyclohexyl acid triazole azoles as LPA antagonists
BRISTOL MYERS SQUIBB CO1 citations62
US11267800B2Mar 8, 2022
Cyclohexyl acid triazole azines as LPA antagonists
BRISTOL MYERS SQUIBB CO2 citations62
US11008300B2May 18, 2021
Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations62
US10000466B2Jun 19, 2018
Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO1 citations62
US9453029B2Sep 27, 2016
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US9079918B2Jul 14, 2015
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US7842708B2Nov 30, 2010
Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO4 citations62
US7517904B2Apr 14, 2009
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO1 citations62
US7381730B2Jun 3, 2008
3-arylquinazoline derivatives as selective estrogen receptor beta modulators
BRISTOL MYERS SQUIBB CO2 citations62
US7105537B2Sep 12, 2006
2-substituted cyclic amines as calcium sensing receptor modulators
BRISTOL MYERS SQUIBB CO4 citations61
USRE49352EJan 3, 2023
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations60
US9745313B2Aug 29, 2017
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US9725435B2Aug 8, 2017
Substituted 4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US9394276B2Jul 19, 2016
Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US9376444B2Jun 28, 2016
Dihydropyridone P1 as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
CORTE JAMES R
3 patentsHANGELAND JON J
2 patentsPINTO DONALD J P
1 patentQUAN MIMI L
1 patentShowing the top 50 of 65 patents by PatentIndex Score.